2004 Feb 265:6
Should this injectable treatment become highly cost-effective and broadly accessible, there is a substantial risk of increased off-label, unprescribed utilization
However, individuals must consult with their medical professionals to ensure they maximize their benefits and achieve their desired results
Food and Drug Administration (FDA), where he leads interdisciplinary review teams in the assessment various complex drug products
Safety & Research Considerations Research-only designation: This product is intended strictly for in vitro and preclinical laboratory research
However, there are also cases when additional factors such as lack of sleep, poor diet, and deficiency of other vitamins like iron, folate, and others, contribute to the issue